<DOC>
	<DOCNO>NCT00893425</DOCNO>
	<brief_summary>In recent year , diabetic nephropathy , may lead dialysis treatment , prevalent underlying disease people develop country . A wide range study carry , various point view , understand progress renal dysfunction diabetic nephropathy . The endogenous nitric oxide synthase ( NOS ) inhibitor asymmetric dimethylarginine ( ADMA ) elevate patient chronic kidney disease ( CKD ) may role cardiovascular mortality morbidity patient . In diabetic nephropathy , high ADMA level relate progression diabetic nephropathy . The Fas ( CD95 ) antigen cell surface polypeptide belong tumor necrosis factor receptor ( TNF-R ) family ( type I membrane protein ) transduces death signal interaction ligand . Apoptotic cell recognize remove phagocyte . Recent study suggest , uremic patient , peripheral blood mononuclear cell undergo accelerate apoptosis correlate Fas level . There data effect Renin angiotensin system blockage ( RAS ) CD95 ADMA level diabetic patient proteinuria . The aim study find whether beneficial effect RAS blockage diabetic proteinuria relation alteration ADMA CD95levels . The investigator search effect ACE inhibitor ramipril clinical laboratory parameter diabetic patient proteinuria .</brief_summary>
	<brief_title>Effect Renin Angiotensin System Blockade Fas Antigen ( CD95 ) Asymmetric Dimethylarginine ( ADMA ) Levels Type-2 Diabetic Patients With Proteinuria</brief_title>
	<detailed_description>The patient non-obese ( BMI &lt; 30 kg/m2 ) , non dyslipidemic ( total cholesterol &lt; 200 mg/dl , Triglyceride &lt; 150mg/dl ) , free cardiovascular event ( negative medical history , negative ECG finding ) investigate enrollment . CKD stage 1 patient old 18 year age willing participate study screen . From 231 patient establish type 2 diabetes mellitus , 126 proteinuria and/or hypertension ( 24 h protein excretion 1-2 g/day , systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg , respectively ) . All case first referral time study treatment . Patients history coronary artery disease , smoker take statin renin-angiotensin blocker exclude effect factor endothelial dysfunction . Of 126 screen patient 78 meet study criterion include study . The duration proteinuria diabetic nephropathy initial diagnosis know . The exclusion criterion follow : A ) Nephrotic syndrome , B ) coronary heart disease ( patient ischemic ST-T alteration voltage criterion LVH electrocardiogram , history revascularization myocardial infarction ) , C ) elevate liver enzyme ( AST ALT level ≥ 40 U/L ) D ) renal failure ( serum creatinine level &gt; 1.3 mg/dl ) . In order evaluate effect RAS blockade plasma PTX3 concentration , patient proteinuria give ACE inhibitor ( ramipril 10 mg/day ) 12 week . The effect RAS blockade insulin sensitivity proteinuria also investigate . After intervention period , blood sample obtain assay plasma PTX3 concentration , HbA1c , insulin resistance score ( HOMA-IR ) . Urine sample also collect 24-hour period determine degree proteinuria .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>N , N-dimethylarginine</mesh_term>
	<criteria>CKD stage 1 patient Older 18 year age Type 2 Diabetic patient Proteinuria History coronary artery disease Smokers Taking statins reninangiotensin blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>CD95</keyword>
	<keyword>ADMA</keyword>
	<keyword>proteinuria</keyword>
	<keyword>diabetic nephropathy</keyword>
	<keyword>CD95 ADMA level</keyword>
</DOC>